Lung Diseases: all 3,319 studies

Page 31 of 34. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.

• Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different SeverityCompletedNCT00274573Phase 3
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.CompletedNCT00274560Phase 3
• Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274547Phase 3
• A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.CompletedNCT00274534Phase 3
• Tiotropium (Spiriva) Rehabilitation StudyCompletedNCT00274521Phase 3
• Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00274092Phase 3
• SPIRIVA in Ususal CareCompletedNCT00274079Phase 4
• Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of SpirivaCompletedNCT00274066Phase 3
• Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDCompletedNCT00274053Phase 3
• Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPDCompletedNCT00274040Phase 3
• Pediatric Asthma Controller Trial (PACT)CompletedNCT00272506Phase 3
• Prevention of Early Asthma in Kids (PEAK)CompletedNCT00272441Not applicable
• Stress, Environment, and Genetics in Urban Children With AsthmaCompletedNCT00269256
• Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)CompletedNCT00269126Phase 3
• Danish Quality Assurance Project on Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in Outpatient Lung ClinicsCompletedNCT00268866
• Aerosol Cyclosporine for Prevention of Lung RejectionCompletedNCT00268515Phase 2
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00268216Phase 3
• Airway Inflammation In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00268177Phase 3
• Evaluation of the Respimat Inhaler vs. a HFA MDI Using Berodual in Patients With COPD With Poor MDI Technique.CompletedNCT00267917Phase 4
• Database of Interstitial Lung DiseasesStatus unknownNCT00267800
• Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPDTerminatedNCT00263874Phase 2
• Sodium Pyruvate Therapy in COPD PatientsCompletedNCT00262613Phase 2
• Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00259909
• Non-invasive Measures of Distal Lung Disease in AsthmaticsCompletedNCT00250341Phase 4
• Pharmacology Study of Aerosolized LiposomalWithdrawnNCT00250120Phase 2
• Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)CompletedNCT00250068Phase 2
• Combination Paclitaxel, Carboplatin and TemozolomideCompletedNCT00249964Phase 1
• Long-term Study of Safety and Efficacy of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-08)CompletedNCT00246935Phase 3
• Effects of Temazepam in Patients With Chronic Pulmonary Obstructive DiseaseCompletedNCT00245661Phase 3
• Possible Relation of Toll-Like Receptors and Nitric Oxide to Chronic Lung DiseaseCompletedNCT00245167
• Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of LifeCompletedNCT00243282Not applicable
• Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119)CompletedNCT00242320Phase 3
• Efficacy and Safety of Roflumilast in Japanese Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (APTA-2217-06)CompletedNCT00242294Phase 2/3
• Family Approach to Managing Asthma in Early TeensCompletedNCT00241852Phase 3
• Prospective Investigation of Pulmonary Embolism Diagnosis IIICompletedNCT00241826
• Optimal Approach for Analysis of Case-Control Genetic Association StudiesCompletedNCT00241709
• Air Pollution, Inflammation, and New Onset AsthmaCompletedNCT00241696
• Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239499Phase 4
• 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDCompletedNCT00239473Phase 3
• Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPDCompletedNCT00239460Phase 3
• Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPDCompletedNCT00239447Phase 3
• A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239434Phase 3
• A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00239421Phase 4
• Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant RecipientsTerminatedNCT00235651Phase 3
• Study of the Economics of Pulmonary Artery Catheter Use in Patients With Acute Respiratory Distress Syndrome (ARDS)CompletedNCT00234767
• Prolonged Outcomes After Nitric Oxide (PrONOx)CompletedNCT00234247
• Factors in Childhood Lung Susceptibility to PollutionCompletedNCT00233285
• Influence of Data Collection Mode on Self-Report Validity of Asthma Therapy AdherenceCompletedNCT00233233Not applicable
• IC14 Antibodies to Treat Individuals With Acute Lung InjuryTerminatedNCT00233207Phase 2
• Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk AdolescentsCompletedNCT00233168Not applicable
• Evaluating Genes in Sputum to Measure Drug Response in COPDTerminatedNCT00233051Not applicable
• Efficacy Study of the Effect of Budesonide on EmphysemaCompletedNCT00232674Phase 4
• Herpesvirus in Idiopathic Pulmonary FibrosisCompletedNCT00228670
• Evaluation of the Lungs of Individuals With Lung DiseaseCompletedNCT00224198
• Evaluation of Lungs of Normal Individuals by Lung Lavage, Brushing and Bronchial Wall BiopsyCompletedNCT00224185
• A Phase 2 Study of the Safety and Efficacy of a Tofimilast in Adult Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00219622Phase 2
• Better Asthma Outcomes: Lowering Tobacco Smoke ExposureCompletedNCT00217958Not applicable
• Does Shared Decision-Making Improve Adherence in AsthmaCompletedNCT00217945Not applicable
• Environmental Tobacco Smoke Exposure Reduction in High-Risk PreteensCompletedNCT00217893Not applicable
• Study in Patients With COPDCompletedNCT00215423Phase 2
• Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202189Phase 4
• Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00202176Phase 4
• Primary Care Management/Action Plans for Advanced Chronic DiseasesCompletedNCT00202150Phase 2/3
• Histoblood Group Antigens as a Risk Factor of AsthmaCompletedNCT00201266
• Trial to Enhance Adherence to Multiple GuidelinesCompletedNCT00201227Not applicable
• Enhancing Collaboration Between Doctors and Patients to Improve AsthmaCompletedNCT00201188Not applicable
• ANTEAB: a Study of Early Antibiotherapy in the ICU Management of Acute Exacerbations of COPDCompletedNCT00190437Phase 4
• How Smoking Causes COPD: Examination of Immune System ChangesStatus unknownNCT00186719
• Selenium Supplementation in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00186706Phase 4
• COPD on Primary Care Treatment (COOPT)CompletedNCT00184977Phase 4
• Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary DiseaseTerminatedNCT00181272Phase 2
• Inhaled Steroid Reduces Systemic Inflammation in COPDCompletedNCT00175565Phase 4
• Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00170222Phase 4
• Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary DiseaseCompletedNCT00164138Not applicable
• A Study of UK-369,003 on the Safety and Efficacy in Patients With COPDCompletedNCT00163098Phase 1/2
• Long Term Effect of an Education and Training Program for Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00159549Not applicable
• The Use of Repetitive Magnetic Stimulation for Strength Training of the Quadriceps MuscleCompletedNCT00159367Not applicable
• Cigarette Smoke Nasal and Whole Blood Challenge in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00159341Phase 1
• Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNCT00159289Not applicable
• Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHFCompletedNCT00156780Phase 1
• Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00153075Phase 4
• Cytokine Change in Bronchoalveolar Lavage Fluid After Early Budesonide-Surfactant Treatment in Premature InfantsTerminatedNCT00146497Phase 4
• ADVAIR® DISKUS® Inhaler (Fluticasone Propionate/Salmeterol) Versus SEREVENT® DISKUS® Inhaler (Salmeterol) For The Treatment Of Chronic Obstructive Pulmonary Disease Exacerbations. ADVAIR® DISKUS® Inhaler and SEREVENT® DISKUS® Inhaler Are Trademarks of the GSK Group of Companies.CompletedNCT00144911Phase 4
• Safety And Anti-Inflammatory Effect Of SB681323 In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144859Phase 2
• A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00144326Phase 3
• The Effect of Cycling Off Criteria During Pressure Support Ventilation in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT00141440Not applicable
• Chinese Community Smoking Cessation ProjectCompletedNCT00139516Not applicable
• Non-invasive Ways to Evaluate Lung Disease After Treatment With XolairCompletedNCT00139152Phase 4
• The Vancouver-BOLD Study: The Burden of Chronic Obstructive Lung DiseaseCompletedNCT00136006
• Immune Dysregulation in Children and Adults With AsthmaCompletedNCT00135681Not applicable
• The Additional Value of Noninvasive Ventilation Next to Rehabilitation in Hypercapnic COPD PatientsStatus unknownNCT00135538Phase 3
• Method of Oxygen Delivery and the Effect on Transcutaneous PaCO2TerminatedNCT00135252Phase 2/3
• Formoterol Certihaler, Tiotropium HandiHaler and Tiotropium HandiHaler in Combination With Formoterol Certihaler in Patients With Stable Chronic Obstructive Pulmonary DiseaseCompletedNCT00134979Phase 4
• Prophylactic Antibiotic Treatment of Patients With Chronic Obstructive Lung Disease (COLD)Status unknownNCT00132860Phase 4
• Gleevec Idiopathic Pulmonary Fibrosis (IPF) StudyCompletedNCT00131274Phase 2/3
• Evaluation of Spirometry Expert Support in General PracticeStatus unknownNCT00131157Not applicable
• A Study in Pediatric Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00130182Phase 2
• The Usefulness of Patients Receiving Their Own Letter After an Outpatient AttendanceCompletedNCT00129636Not applicable
• Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary RehabilitationStatus unknownNCT00129350Phase 1
• Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General PracticeCompletedNCT00128765Not applicable

← Lung Diseases overview